A comprehensive view of New England Journal of Medicine. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

New England Journal of Medicine publishes Phase 3 data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Published: February 25, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
Positive phase 2 trial data shows high-efficacy of novel Sanofi drug frexalimab in reducing disease activity in relapsing multiple sclerosis with 89% reduction in new brain lesions; phase 3 trials currently underway
Published: February 15, 2024 by Sanofi SA
Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine
Published: February 07, 2024 by Janssen Pharmaceutical Companies

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count